This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
- CDC:
- Centers for Disease Control and Prevention
- ESBL:
- extended-spectrum β-lactamase
- MDRO:
- multidrug-resistant organism
- MRSA:
- methicillin-resistant Staphylococcus aureus
- VRE:
- vancomycin-resistant Enterococcus
Abstract
Antibiotic-resistant bacteria are an increasing problem in the NICU. Ineffective empiric antibiotic therapy is associated with increased risk for morbidity and mortality. Organisms that are resistant to multiple antimicrobial agents (multidrug-resistant organisms) are particularly problematic. These organisms may be transmitted to infants if infection control practices are not adhered to, or they may be created by antibiotic exposure. Therefore, meticulous infection prevention—including hand hygiene, surveillance cultures, contact precautions, and selective decolonization—and antibiotic stewardship are important strategies to minimize drug resistance in the NICU.
- Copyright © 2019 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.